-
GLP-1 drugs and eye health risks: A new watchlist for diabetes patients
19 Jun 2025 23:56 GMT
… medications faced more than double the risk of developing neovascular age-related macular degeneration … Meenal Agarwal, who treats diabetic patients, reinforced … “Don’t stop treatment abruptly. Instead, engage … Wegovy, defended its drugs, citing “robust” …
-
Efficacy and Safety of Aflibercept Biosimilars Relative to Reference Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
19 Jun 2025 17:34 GMT
… which developed by Qilu Pharmaceutical in China … treatment of neovascular age-related macular degeneration (nAMD). The occurrence of treatment … macular degeneration: a randomized phase 3 trial. … Drug Administration; 2020. Available: https://www.fda …
-
RGD-Functionalized Ginsenoside Rg3 Liposomes for Alleviating Oxidative Stress and Choroidal Neovascularization in Age-Related Macular Degeneration
19 Jun 2025 17:34 GMT
… be effective in treating AMD, such as … nonexudative age-related macular degeneration: physiopathology and treatment options. Int … of drugs for vitreoretinal diseases. Adv Drug Deliv … damage and development of age‐related macular degeneration. Acta Ophthalmol …
-
Seeing Beyond Sight: New Frontiers in AMD Treatment-Gene Therapy and Biosimilars Take Center Stage | CI Intelligence
19 Jun 2025 17:53 GMT
… off-label.
Recent Developments:
Biosimilars: Byooviz … ALK-001 (Alkeus Pharmaceuticals): A modified … remain:
- Treatment Burden: Monthly … macular-degeneration-amd
🎯 Target Opportunity Profile (TOP): Strategic Drug Benchmarking
Ideal Drug …
-
Annexon Bolsters Ophthalmology Expertise with Appointment of Retina Specialist Lloyd Clark, M.D., as Pivotal ANX007 Program Advances in Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy (GA)
18 Jun 2025 20:05 GMT
… of Experience Treating Retina Diseases and Developing Emerging Therapies … Atrophy
Dry age-related macular degeneration (AMD) is the … and emotional hardship. Effective treatments that preserve vision are … ophthalmology drug approvals by the U.S. FDA and …
-
Weight-Loss Drug Ozempic Tied to Vision Loss Risks: What Indian Users Need to Know
18 Jun 2025 18:22 GMT
… medications have a twofold increased risk of developing neovascular age-related macular degeneration … be encouraged, and pre-treatment eye tests should be … pharma giants drive weight-loss medications'; popularity, India’s burgeoning interest in drugs …
-
Neovascular macular degeneration risk increased by semaglutide use
17 Jun 2025 05:57 GMT
… twice as likely to develop neovascular age-related macular degeneration (nAMD) compared to … those not using the weight loss drug … , central vision.
Traditionally used to treat type 2 diabetes, semaglutide has …
-
Blind Spots: Comparing the Vision Costs of Weight-Loss Drugs
18 Jun 2025 10:22 GMT
… had taken semaglutide and developed severe optic neuropathy. … drugs had a twofold higher risk for neovascular age-related macular degeneration … taking other weight-loss medications, such as the … Drug, New Insights
Approved by the FDA in 1959 for the treatment …
-
Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types
16 Jun 2025 17:00 GMT
… AMD. These injectable medications can slow disease … drugs. Several companies with their lead products, such as Alkeus Pharmaceuticals … first anti-VEGF drug used was bevacizumab … developing therapies for the treatment of wet age-related macular degeneration. …
-
Popular Diabetes Drug Doubles Risk of an Age-Related Eye Condition
18 Jun 2025 00:07 GMT
… loss drugs may face double the risk of developing a … the risk of developing neovascular age-related macular degeneration (nAMD), also … of GLP-1 users developed the eye condition … develop the condition. However, with millions of people taking these medications …
About
© 1995-2025